Apr 28, 2020 18:21 JST
Source: mazda
|
|
|
Mazda Production and Sales Results for March 2020 and for April 2019 through March 2020
TOKYO, Apr 28, 2020 - (JCN Newswire) - Mazda Motor Corporation's production and sales results for March 2020 and for April 2019 through March 2020 are summarized below.
I. Production
1. Domestic Production
(1) March 2020 Mazda's domestic production volume in March 2020 decreased 17.6% year on year due to decreased production of passenger vehicles.
[Domestic production of key models in March 2020] CX-5: 29,796 units (down 25.0% year on year) MAZDA3: 9,932 units (down 10.8%) CX-30: 9,322 units
(2) April 2019 through March 2020 Mazda's domestic production volume in the period from April 2019 through March 2020 decreased 3.8% year on year due to decreased production of passenger and commercial vehicles.
[Domestic production of key models in the period from April 2019 through March 2020] CX-5: 388,565 units (down 10.8% year on year) MAZDA3 (includes Axela): 168,837 units (up 7.6%) CX-30: 84,933 units
2. Overseas Production
(1) March 2020 Mazda's overseas production volume in March 2020 decreased 24.8% year on year due to decreased production of passenger and commercial vehicles.
[Overseas production of key models in March 2020] CX-30: 9,967 units MAZDA3: 8,638 units (down 50.0% year on year) MAZDA2: 6,080 units (down 54.0%)
(2) April 2019 through March 2020 Mazda's overseas production volume in the period from April 2019 through March 2020 decreased 17.4% year on year due to decreased production of passenger and commercial vehicles.
[Overseas production of key models in the period from April 2019 through March 2020] MAZDA3: 126,999 units (down 37.5% year on year) MAZDA2: 92,439 units (down 23.2%) CX-4: 50,520 units (down 10.3%)
II. Domestic Sales
(1) March 2020 Mazda's domestic sales volume in March 2020 increased 8.1% year on year due to increased sales of passenger and commercial vehicles. Mazda's registered vehicle market share was 6.5% (up 0.8 points year on year), with a 3.0% share of the micro-mini segment (up 1.1 points) and a 5.2% total market share (up 0.8 points).
[Domestic sales of key models in March 2020] CX-30: 5,643 units MAZDA2 (includes Demio): 5,621 units (down 13.1% year on year) CX-5: 4,196 units (down 33.8%)
(2) April 2019 through March 2020 Mazda's domestic sales volume in the period from April 2019 through March 2020 decreased 5.7% year on year due to decreased sales of passenger and commercial vehicles. Mazda's registered vehicle market share was 5.2% (unchanged year on year), with a 2.0% share of the micro-mini segment (down 0.1 points) and a 4.0% total market share (down 0.1 points).
[Domestic sales of key models in the period from April 2019 through March 2020] MAZDA2 (includes Demio): 35,405units (down 19.3% year on year) MAZDA3 (includes Axela): 33,403 units (up 120.6%) CX-5: 27,726 units (down 30.6%)
III. Exports
(1) March 2020 Mazda's export volume in March 2020 decreased 30.2% year on year due to decreased shipments to North America, Europe and other regions.
[Exports of key models in March 2020] CX-5: 24,048 units (down 29.3% year on year) MAZDA3: 6,443 units (down 46.2%) MAZDA6: 4,792 units (down 32.0%) (2) April 2019 through March 2020 Mazda's export volume in the period from April 2019 through March 2020 decreased 3.2% year on year due to decreased shipments to Europe, Oceania and other regions.
[Exports of key models in the period from April 2019 through March 2020] CX-5: 359,992 units (down 8.2% year on year) MAZDA3: 135,338 units (down 4.2%) CX-3: 74,208 units (down 38.1%)
IV. Global Sales
(1) March 2020 Mazda's global sales volume in March 2020 decreased 32.8% year on year due to decreased sales in the U.S., China, Europe and other regions.
[Global sales of key models in March 2020] CX-5: 26,215 units (down 43.5% year on year) MAZDA3: 18,765 units (down 38.1%) CX-30: 15,437 units
(2) April 2019 through March 2020 Mazda's global sales volume in the period from April 2019 through March 2020 decreased 9.1% year on year due to decreased sales in the U.S., China, Europe and other regions.
[Global sales of key models in the period from April 2019 through March 2020] CX-5: 415,708 units (down 9.3% year on year) MAZDA3 (includes Axela): 309,053 units (down 14.6%) MAZDA2 (includes Demio): 138,886 units (down 18.0%)
For more information, visit https://bit.ly/2Sdg2IX.
Source: mazda Sectors: Automotive
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
|
Latest Release
 Mazda Presents World Premiere of Two Vision Models at Japan Mobility Show 2025 Oct 30, 2025 14:33 JST
|  Mazda Rolls Out New Version of Brand Symbol from Japan Mobility Show 2025
Oct 30, 2025 14:26 JST
|  NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI Oct 30, 2025 14:18 JST
|  Overview of Honda CEO Speech at the Japan Mobility Show 2025 Oct 30, 2025 14:00 JST
|  Honda Presents World Premiere of the Prototype of Honda 0 a, new SUV Model for Honda 0 Series at Japan Mobility Show 2025 Oct 30, 2025 11:55 JST
|  Honda Presents World Premiere of Super-ONE Prototype Compact EV at Japan Mobility Show 2025 Oct 30, 2025 11:50 JST
|  Mitsubishi Motors Debuts Mitsubishi Elevance Concept and Adventure-Inspiring Lineup at Japan Mobility Show 2025 Oct 30, 2025 11:39 JST
|  Fujitsu and PwC Japan partner on economic security measures for sovereign cloud solution Oct 30, 2025 11:22 JST
|  Hitachi Rail becomes world's first transportation firm to adopt new NVIDIA IGX Thor solution for real-time AI Oct 30, 2025 11:00 JST
|  Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma Oct 30, 2025 00:53 JST
|  Olympus Introduces NBI+TXI(TM) Observation Mode to the EVIS X1(TM) Endoscopy System CV-1500 Video System Center Oct 30, 2025 00:30 JST
|  Gannon & Scott has signed a definitive agreement to join Metalor Technologies Oct 30, 2025 00:30 JST
|  Merck & Co., Inc. and Eisai Announce WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carcinoma Oct 29, 2025 00:30 JST
|  Mitsubishi Heavy Industries Machinery Systems to Exhibit at Japan Mobility Show 2025 Oct 29, 2025 00:00 JST
|  Fujitsu AI transforms regional healthcare in Iki city Oct 28, 2025 23:24 JST
|  Hitachi announces initiatives aligned with Japan - U.S. strategic investments Oct 28, 2025 22:34 JST
|  NEC Achieves Cisco Gold Provider Status, Strengthening Global Strategic Partnership in the AI era Oct 28, 2025 22:09 JST
|  Honda to Invest in OMC Power, which will Launch Leasing Business for Uninterruptible Power Supply Device in India Oct 27, 2025 21:20 JST
|  Fujitsu, Logistics Knight Japan, and Isuzu Motors launch joint pilot project to build pharmaceutical logistics platform aiming for stable supply Oct 27, 2025 17:31 JST
|  JCB Explores Opportunities to Expand Card Acceptance through Partnership with STC Bank Oct 27, 2025 15:00 JST
|
More Latest Release >>
|